**Chapter 9**

*Psychopathology - An International and Interdisciplinary Perspective*

[62] Stein MB et al. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders. Psychiatric Services.

[63] Susman J, Klee B. The role of high-potency benzodiazepines in the treatment of panic disorder prim care companion. The Journal of Clinical

[64] Toni C et al. Spontaneous treatment discontinuation in panic disorder patients treated with antidepressants. Acta Psychiatrica Scandinavica.

[65] Van Rijn B, Wild C. Humanistic and integrative therapies for anxiety and depression: Practicebased evaluation of transactional analysis, gestalt and integrative psychotherapies and person centered counseling. Transactional Analysis Journal. 2013;**43**(2):150-163. DOI:

[66] Weissman M. Family genetic studies of panic disorder. Journal of Psychiatric

Psychiatry. 2005;**7**(1):5-11

10.1177/036253713499545

Research. 1993;**27**(1):69-78

[67] Wesner C et al. Effect of cognitive-behavioral group therapy for panic disorder in changing coping strategies. Comprehensive Psychiatry. 2013;**55**(1):87-92. DOI: 10.1016/j.

comppsych.2013.06.008

2006;**57**:673-680

2004;**110**:130-137

[53] Rodrigues H et al. CBT for pharmacotherapy non-remitters—A systematic review of a next-step

Neurosciences. 2007;**61**:449

Genetics. 2011;**48**:361-368

[56] Sepede G et al. Olanzapine augmentation in treatment-resistant panic disorder: A 12-week, fixed-dose, open-label trial. Journal of Clinical Psychopharmacology. 2006;**26**(1):45-49

[57] Simon NM et al. Next-step

to initial pharmacotherapy: A 3-phase randomized clinical trial. The Journal of Clinical Psychiatry.

2009;**70**(11):1563-1570

strategies for panic disorder refractory

[58] Simon NM et al. Open-label support for duloxetine for the treatment of panic disorder. CNS Neuroscience & Therapeutics. 2009;**15**(1):19-23. DOI: 10.1111/j.1755-5949.2008.00076.x

[59] Smits JAJ, O'Cleirigh CM, Otto MW. Combining cognitive-behavioral therapy and pharmacotherapy for the treatment of panic disorder. Journal of Cognitive Psychotherapy. 2006;**20**:75-84

[60] Spatola C et al. Gene–environment interactions in panic disorder and CO2 sensitivity: Effects of events occurring early in life. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics.

Escitalopram in the treatment of panic disorder: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry. 2003;**64**:1322-1327

2011;**129**:219-228

strategy. Journal of Affective Disorders.

[54] Saito M, Miyaoka H. Augmentation of paroxetine with clocapramine in panic disorder. Psychiatry and Clinical

[55] Schumacher J et al. The genetics of panic disorder. Journal of Medical

**128**

2011;**79-88**(34):56

[61] Stahl SM, Gergel I, Li D.
